Apollomics Reports First Half 2023 Financial Results and Provides Corporate Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
Phase 2 data from vebreltinib (APL-101), a highly selective cMet inhibitor, in patients with NSCLC with MET exon14 skipping mutation expected second half.
Shares of Maxpro Capital Acquisition Corp. (NASDAQ:JMAC – Get Free Report) dropped 1.3% during trading on Tuesday . The stock traded as low as $3.95 and last traded at $3.95. Approximately 5,648 shares were traded during trading, a decline of 92% from the average daily volume of 74,040 shares. The stock had previously closed at […]